EXPO · Exponent Inc
Market Cap
$3.34B
Shares
47.55M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$582.01M
+4.2%
FY2025
Net Income
$106.01M
-2.7%
FY2025
Operating Margin
20.58%
-0.8pp
FY2025
Diluted EPS
$2.07
-1.9%
FY2025
Operating Cash Flow
$131.73M
-8.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $632.46M | $582.01M | $558.51M | $536.77M | $513.29M | $466.27M | $399.9M | $417.2M | $379.52M | $347.8M | $315.08M | $312.83M | $304.7M | $296.17M | $292.65M | $272.45M | $248.75M | $227.88M | |
| $27.98M | $25.52M | $22.73M | $24.44M | $23.66M | $15.28M | $12.89M | $20.52M | $17.53M | $17.78M | $15.49M | $15.3M | $15.84M | $14.71M | $13.56M | $13.12M | $12.36M | $11.01M | |
| $10.26M | $10.08M | $9.69M | $8.92M | $7.08M | $6.49M | $6.87M | $6.81M | $6.29M | $6.29M | $6.13M | $5.48M | $5.4M | $4.95M | $4.71M | $4.41M | $4.32M | $4.35M | |
| $504.88M | $462.23M | $438.96M | $425.44M | $372.45M | $357.34M | $316.65M | $332.09M | $288.07M | $275.75M | $253.17M | $243.9M | $241.16M | $240.22M | $235.03M | $218.99M | $205.51M | $194.62M | |
| $127.58M | $119.79M | $119.56M | $111.32M | $140.84M | $108.93M | $83.25M | $85.11M | $91.46M | $72.05M | $61.91M | $68.93M | $63.55M | $55.95M | $57.62M | $53.46M | $43.24M | $33.26M | |
| — | 20.58% | 21.41% | 20.74% | 27.44% | 23.36% | 20.82% | 20.4% | 24.1% | 20.72% | 19.65% | 22.04% | 20.86% | 18.89% | 19.69% | 19.62% | 17.38% | 14.6% | |
| $137.84M | $129.87M | $129.25M | $120.24M | $147.92M | $115.41M | $90.12M | $91.92M | $97.75M | $78.34M | $68.04M | $74.41M | $68.95M | $60.9M | $62.33M | $57.87M | $47.56M | $37.61M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $328K | $236K | $198K | $614K | |
| $18.94M | $18.2M | $17.81M | $17.42M | -$10.7M | $16.84M | $11.98M | $15.17M | -$890K | $9.16M | $6.53M | $1.99M | $4.27M | $7.87M | $3.8M | $1.12M | $3.47M | $3.15M | |
| $155.83M | $147.3M | $147.37M | $135.9M | $132.23M | $125.84M | $96.94M | $104.19M | $93.32M | $82.51M | $69.12M | $71.13M | $67.97M | $63.95M | $61.75M | $54.82M | $46.71M | $37.02M | |
| $44.06M | $41.29M | $38.37M | $35.56M | $29.9M | $24.64M | $14.38M | $21.73M | $21.06M | $41.2M | $21.64M | $27.53M | $27.26M | $25.31M | $24.52M | $22.12M | $19.19M | $14.89M | |
| $111.77M | $106.01M | $109M | $100.34M | $102.33M | $101.2M | $82.55M | $82.46M | $72.25M | $41.31M | $47.48M | $43.6M | $40.7M | $38.64M | $37.23M | $32.7M | $27.52M | $22.13M | |
| — | 18.21% | 19.52% | 18.69% | 19.94% | 21.7% | 20.64% | 19.77% | 19.04% | 11.88% | 15.07% | 13.94% | 13.36% | 13.05% | 12.72% | 12% | 11.06% | 9.71% | |
| $111.89M | $107.51M | $108.19M | $100.95M | $100.73M | $101.15M | $82.38M | $83.55M | $71.43M | $42.4M | $46.16M | $42.7M | $39.69M | $39M | $37.45M | $32.68M | $27.44M | $22.11M | |
| USD/shares | $2.23 | $2.08 | $2.13 | $1.96 | $1.98 | $1.92 | $1.58 | $1.56 | $1.37 | $0.78 | $0.90 | $1.64 | $1.51 | $1.42 | $2.70 | $2.31 | $1.92 | $1.56 |
| USD/shares | $2.22 | $2.07 | $2.11 | $1.94 | $1.96 | $1.90 | $1.55 | $1.53 | $1.33 | $0.77 | $0.87 | $1.60 | $1.47 | $1.38 | $2.60 | $2.22 | $1.83 | $1.47 |
| shares | — | 50.9M | 51.13M | 51.15M | 51.73M | 52.61M | 52.39M | 52.69M | 52.91M | 52.72M | 52.98M | 26.61M | 26.91M | 27.23M | 13.78M | 14.18M | 14.35M | 14.19M |
| shares | — | 51.24M | 51.57M | 51.64M | 52.28M | 53.33M | 53.32M | 53.88M | 54.17M | 53.97M | 54.33M | 27.3M | 27.67M | 28.05M | 14.29M | 14.75M | 15.07M | 15.03M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $579.41M in buybacks, $443.98M in dividends.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 30 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.55×
EV/EBIT
—
Peer median 20.14×
P/E (TTM)
31.61×
Peer median 28.33×
Peer medians compare against the 25 similar-size Engineering & Construction companies (of 41 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Engineering and Other Scientific | $493,893,000 | $469,544,000 | $446,888,000 | $427,796,000 | $380,909,000 | $319,346,000 | $339,796,000 | $306,265,000 |
| Environmental and Health | $88,121,000 | $88,970,000 | $89,878,000 | $85,497,000 | $85,360,000 | $80,554,000 | $77,403,000 | $73,258,000 |
By Geography (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| United States | $520,591,000 | $493,067,000 | $470,078,000 | $450,445,000 | $397,001,000 | $353,565,000 | $351,856,000 | $334,422,000 |
| Non Us | $61,423,000 | $65,447,000 | $66,688,000 | — | — | — | — | — |
| Foreign Countries | — | — | — | $62,848,000 | $69,268,000 | $46,335,000 | $65,343,000 | $45,101,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Engineering and Other Scientific | $173,625,000 | $164,883,000 | $153,918,000 | $152,679,000 | $140,400,000 | $100,616,000 | $110,822,000 | $100,307,000 |
| Environmental and Health | $30,558,000 | $29,995,000 | $28,432,000 | $27,340,000 | $27,952,000 | $26,728,000 | $26,589,000 | $23,824,000 |
Operating Margin by Segment (%)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Engineering and Other Scientific | 35.2% | 35.1% | 34.4% | 35.7% | 36.9% | 31.5% | 32.6% | 32.8% |
| Environmental and Health | 34.7% | 33.7% | 31.6% | 32% | 32.7% | 33.2% | 34.4% | 32.5% |
Key facts
CIK
851520
CUSIP
30214U102
13F (30d)
242 filings
242 filers
Visit website
Investor relations